TY - JOUR
T1 - Preface
T2 - Guidelines for the treatment of travelers’ diarrhea in deployed military personnel
AU - Riddle, Mark S.
AU - Tribble, David
N1 - Funding Information:
This work was supported by the Infectious Disease Clinical Research Program, a Department of Defense program executed through the Uniformed Services University of the Health Sciences, Department of Preventive Medicine and Biostatistics. This project has been funded by the National Institute of Allergy and Infectious Diseases, National Institute of Health [Inter-Agency Agreement Y1-AI-5072]. This work was supported by a grant from the Bureau of Medicine and Surgery to the Uniformed Services University of the Health Sciences (USU Grant Agreement-HU0001-11-1-0022; USU Project No: G187V2)
Publisher Copyright:
© Association of Military Surgeons of the U.S. All rights reserved.
PY - 2017/9
Y1 - 2017/9
N2 - Diarrheal disease frequently affects military personnel deployed to developing countries, resulting in decreased job performance and potential negative impacts on military operational readiness. Travelers’ diarrhea is a self-limiting illness; however, antibiotic treatment (with and without use of adjunct loperamide therapy) has been shown to significantly reduce clinical presentation of symptoms and duration of illness. Nonetheless, the choice of first-line antibiotics must be carefully considered as increasing resistance of enteric pathogens in endemic regions has rendered many first-line antibiotics ineffective (e.g., Campylobacter spp. are resistant to fluoroquinolones in Southeast Asia). Presently, there are no standardized recommendations for the treatment of travelers’ diarrhea among deployed military personnel. Therefore, an expert panel was convened to develop evidence-based, consensus-driven guidelines that address key clinical issues related to self-treatment, antibiotic treatment for acute watery diarrhea and febrile diarrhea/dysentery, and diagnostics. These guidelines “Management of Acute Diarrheal Illness during Deployment” are published in this supplement along with articles reviewing the evidence-based data that supported their development.
AB - Diarrheal disease frequently affects military personnel deployed to developing countries, resulting in decreased job performance and potential negative impacts on military operational readiness. Travelers’ diarrhea is a self-limiting illness; however, antibiotic treatment (with and without use of adjunct loperamide therapy) has been shown to significantly reduce clinical presentation of symptoms and duration of illness. Nonetheless, the choice of first-line antibiotics must be carefully considered as increasing resistance of enteric pathogens in endemic regions has rendered many first-line antibiotics ineffective (e.g., Campylobacter spp. are resistant to fluoroquinolones in Southeast Asia). Presently, there are no standardized recommendations for the treatment of travelers’ diarrhea among deployed military personnel. Therefore, an expert panel was convened to develop evidence-based, consensus-driven guidelines that address key clinical issues related to self-treatment, antibiotic treatment for acute watery diarrhea and febrile diarrhea/dysentery, and diagnostics. These guidelines “Management of Acute Diarrheal Illness during Deployment” are published in this supplement along with articles reviewing the evidence-based data that supported their development.
UR - http://www.scopus.com/inward/record.url?scp=85029147694&partnerID=8YFLogxK
U2 - 10.7205/MILMED-D-17-00066
DO - 10.7205/MILMED-D-17-00066
M3 - Article
C2 - 28885917
AN - SCOPUS:85029147694
SN - 0026-4075
VL - 182
SP - 1
EP - 3
JO - Military Medicine
JF - Military Medicine
ER -